Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Monique Andersson
Gonorrhoea: rising cases and antimicrobial resistance
Peter Davis, infectious diseases and microbiology specialist registrar1 2, Eloise Williams, clinical microbiologist and infectious diseases physician3 4, Monique I Andersson, consultant in clinical infection, associate professor25, Odile B Harrison, research fellow6, Susanne H Hodgson, consultant physician in infectious diseases and microbiology and clinician scientist1 1The Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK 2Department of Microbiology, Oxford...
Author Correction: The plasmidome associated with Gram-negative bloodstream infections: a large-scale observational study using complete plasmid assemblies | Nature Communications
Correction to: Nature Communications https://doi.org/10.1038/s41467-024-45761-7, published online 22 February 2024 In this article the author name William Matlock was incorrectly written as Willam Matlock. The original article has been corrected.
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients - Nature Communications
|
Abstract Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been elucidated in at-risk populations. Non-hospitalised participants within 5 days of SARS-CoV-2 symptoms randomised to receive molnupiravir (n = 253) or Usual Care (n = 324) were recruited to study viral and antibody dynamics and the effect of molnupiravir on viral whole genome sequence from 1437 viral genomes. Molnupiravir accelerates viral load decline, but virus is detectable by Day 5 in most cases.
By Joseph F Standing, Laura Buggiotti, Claire Smith, Theo Sanderson, Fiona Ashford, Adrian Shields, Jienchi Dorward, Duncan Richards, Najib M. Rahman, Ly-Mee Yu, Nigel Hart, Philip Evans, Monique Andersson, Kerenza Hood, Jonathan S. Nguyen-Van-Tam, Saye Khoo, Christopher Butler, David Lowe, Judith Breuer
|
Nature
Verified
The plasmidome associated with Gram-negative bloodstream infections: A large-scale observational study using complete plasmid assemblies - Nature Communications
Abstract Plasmids carry genes conferring antimicrobial resistance and other clinically important traits, and contribute to the rapid dissemination of such genes. Previous studies using complete plasmid assemblies, which are essential for reliable inference, have been small and/or limited to plasmids carrying antimicrobial resistance genes (ARGs). In this study, we sequenced 1,880 complete plasmids from 738 isolates from bloodstream infections in Oxfordshire, UK.
Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?
Anti-HBc Antibodies against the hepatitis B virus core antigen Anti-HBe Antibodies against the hepatitis B virus e antigen Anti-HBs Antibodies against the hepatitis B virus surface antigen cccDNA covalently closed circular DNA CHB Chronic hepatitis B virus infection ER endoplasmic reticulum FFP fresh frozen plasma HBcAg Hepatitis B virus core antigen HBcrAg Hepatitis B virus core-related antigen HBeAg Hepatitis B virus e antigen HBsAg Hepatitis B virus surface antigen HBV hepatitis B virus...
Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa - Nature Communications
Systematic review for relevant cohorts We searched PubMed, Scopus, the African Index Medicus and African Journals Online for articles published until 12th July 2022 using a search strategy covering the synonyms of “hepatitis B” AND (“TE” OR “liver biopsy”) AND “sSA” (Supplementary Table 7). Two investigators independently screened all identified articles and reviewed potentially eligible full-text articles for eligibility without language restrictions.
Frequencies and patterns of microbiology test requests from primary care in Oxfordshire, UK, 2008-2018: a retrospective cohort study of electronic health records to inform point-of-care testing | BMJ Open
Frequencies and patterns of microbiology test requests from primary care in Oxfordshire, UK, 2008–2018: a retrospective cohort study of electronic health records to inform point-of-care testing http://orcid.org/0000-0002-8965-104XJM Ordóñez-Mena1,2, Thomas R Fanshawe1, Dona Foster3, Monique Andersson4, Sarah Oakley4, Nicole Stoesser2,3,4, A.
Time to integrate congenital CMV testing into hearing screening for newborn babies
We congratulate the GBD Hearing Loss Collaborators for highlighting the magnitude of hearing loss as an important public health problem. Early detection of hearing loss in children can substantially improve their academic performance. Congenital cytomegalovirus (CMV) is the most common non-genetic and the only potentially treatable cause of sensorineural hearing loss; globally, it alone accounts for approximately 20% of moderate to profound bilateral sensorineural hearing loss in children.
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Summary Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. Serology is considered key to population-level surveillance and potentially individual-level risk assessment. However, immunoassay performance has not been compared on large, identical sample sets.
Head-to-head benchmark evaluation of the sensitivity and specificity of five immunoassays for SARS-CoV-2 serology on >1500 samples
Published on 2020-07-08T08:35:09Z (GMT) by <div>Mark Ainsworth, Monique Andersson, Kathryn Auckland, J. Kenneth Baillie, Eleanor Barnes, Sally Beer, Amy Beveridge, Sagida Bibi, Luke Blackwell, Martyna Borak, Abbie Bown, Tim Brooks, Nicola A. Burgess-Brown, Susana Camara, Matthew Catton, Kevin K. Chau, Thomas Christott, Elizabeth Clutterbuck, Jesse Coker, Richard Cornall, Stuart Cox, David Crawford-Jones, Derrick W.
Rapid roll out of SARS-CoV-2 antibody testing-a concern
News & Views Rapid roll out of SARS...
Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
Emily R Adams, Rekha Anand, Monique I Andersson, Kathryn Auckland, J Kenneth Baillie, Eleanor Barnes, John Bell, Tamsin Berry, Sagida Bibi, Miles Carroll, Senthil Chinnakannan, Elizabeth Clutterbuck, Richard J Cornall, Derrick W Crook, Thushan De Silva, Wanwisa Dejnirattisai, Kate E Dingle, Christina Dold, David W Eyre, Helen Farmer, Sarah J Hoosdally, Alistair Hunter, Katie Jeffrey, Paul Klenerman, Julian Knight, Clarice Knowles, Andrew J Kwok, Ullrich Leuschner, Chang Liu, Cesar...
Africa: The Risk of Early Liver Cancer Is Spurred By a Combo of Hepatitis B and HIV
analysis By Monique Andersson, Stellenbosch UniversityPeople who have both hepatitis B and HIV may have a greater chance of developing liver cancer at a young age, according to our new study. The study, to be published shortly, involved patients from cancer units. The results showed that the age profile of liver cancer patients was affected by HIV. Liver cancer in Africans occurs at a young age: between the ages of 30 and 40 years.
The risk of early liver cancer is spurred by a combo of hepatitis B and HIV
People who have both hepatitis B and HIV may have a greater chance of developing liver cancer at a young age, according to our new study. The study, to be published shortly, involved patients from cancer units. The results showed that the age profile of liver cancer patients was affected by HIV. Liver cancer in Africans occurs at a young age: between the ages of 30 and 40 years. But we found that it occurs at a significantly younger age in those who are infected with HIV and hepatitis B.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Monique
Contact Monique, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack